STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.


Journal

Molecular systems biology
ISSN: 1744-4292
Titre abrégé: Mol Syst Biol
Pays: England
ID NLM: 101235389

Informations de publication

Date de publication:
04 2020
Historique:
received: 19 09 2019
revised: 13 03 2020
accepted: 18 03 2020
entrez: 24 4 2020
pubmed: 24 4 2020
medline: 4 2 2021
Statut: ppublish

Résumé

Prostate cancer (PCa) has a broad spectrum of clinical behavior; hence, biomarkers are urgently needed for risk stratification. Here, we aim to find potential biomarkers for risk stratification, by utilizing a gene co-expression network of transcriptomics data in addition to laser-microdissected proteomics from human and murine prostate FFPE samples. We show up-regulation of oxidative phosphorylation (OXPHOS) in PCa on the transcriptomic level and up-regulation of the TCA cycle/OXPHOS on the proteomic level, which is inversely correlated to STAT3 expression. We hereby identify gene expression of pyruvate dehydrogenase kinase 4 (PDK4), a key regulator of the TCA cycle, as a promising independent prognostic marker in PCa. PDK4 predicts disease recurrence independent of diagnostic risk factors such as grading, staging, and PSA level. Therefore, low PDK4 is a promising marker for PCa with dismal prognosis.

Identifiants

pubmed: 32323921
doi: 10.15252/msb.20199247
pmc: PMC7178451
doi:

Substances chimiques

Biomarkers, Tumor 0
PDK4 protein, human 0
Pyruvate Dehydrogenase Acetyl-Transferring Kinase 0
STAT3 Transcription Factor 0
STAT3 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e9247

Informations de copyright

© 2020 The Authors. Published under the terms of the CC BY 4.0 license.

Références

OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
Cell Metab. 2017 Feb 7;25(2):374-385
pubmed: 28178567
J Biol Chem. 2002 Aug 23;277(34):30409-12
pubmed: 12087111
J Proteome Res. 2005 Nov-Dec;4(6):2397-403
pubmed: 16335993
EMBO Mol Med. 2012 Mar;4(3):218-33
pubmed: 22294553
Bioinformatics. 2018 Jun 1;34(11):1937-1938
pubmed: 29360956
Nat Rev Cancer. 2019 Feb;19(2):82-96
pubmed: 30578415
Oncogene. 2014 Mar 27;33(13):1670-9
pubmed: 23604114
Nat Commun. 2015 Jul 22;6:7736
pubmed: 26198641
Mol Cell Biol. 2002 Nov;22(22):7820-30
pubmed: 12391151
Nat Genet. 2018 Feb;50(2):219-228
pubmed: 29335542
Cancer Res. 2017 Nov 1;77(21):e51-e54
pubmed: 29092939
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
Aging (Albany NY). 2010 Nov;2(11):823-42
pubmed: 21084727
Cell Mol Life Sci. 2014 Jul;71(14):2577-604
pubmed: 24363178
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Exp Mol Med. 2013 Oct 04;45:e45
pubmed: 24091747
Cold Spring Harb Protoc. 2011 Feb 01;2011(2):pdb.prot5573
pubmed: 21285273
J Biol Chem. 2014 Oct 24;289(43):29739-49
pubmed: 25164809
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Nucleic Acids Res. 2019 Jan 8;47(D1):D590-D595
pubmed: 30321428
BMC Bioinformatics. 2007 Jan 24;8:22
pubmed: 17250769
Cancer Cell. 2010 Jul 13;18(1):11-22
pubmed: 20579941
Cancers (Basel). 2014 Jul 31;6(3):1579-96
pubmed: 25089666
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Pathol. 2012 Jul;227(3):286-97
pubmed: 22553170
J Am Soc Mass Spectrom. 2011 Aug;22(8):1373-80
pubmed: 21953191
Analyst. 2018 Dec 17;144(1):220-229
pubmed: 30411762
PLoS One. 2012;7(9):e46324
pubmed: 23050013
Immunity. 2001 May;14(5):523-34
pubmed: 11371355
Genome Biol. 2014 Aug 26;15(8):426
pubmed: 25155515
Neoplasia. 2011 Aug;13(8):692-703
pubmed: 21847361
Diabetes Metab J. 2015 Jun;39(3):188-97
pubmed: 26124988
Actas Urol Esp. 2014 Apr;38(3):143-9
pubmed: 24206626
Mol Cancer Res. 2008 Jul;6(7):1099-105
pubmed: 18644974
Clin Cancer Res. 2016 Feb 1;22(3):691-703
pubmed: 26405196
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
BMC Med Genomics. 2010 Mar 16;3:8
pubmed: 20233430
Mol Biol Rep. 2015 Apr;42(4):841-51
pubmed: 25689954
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Nucleic Acids Res. 2016 Dec 1;44(21):10277-10291
pubmed: 27694626
J Cancer. 2019 Jan 29;10(4):918-926
pubmed: 30854098
Am J Cancer Res. 2018 Sep 01;8(9):1725-1738
pubmed: 30323966
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Front Physiol. 2017 Feb 21;8:97
pubmed: 28270771
Cell Rep. 2015 Aug 11;12(6):922-36
pubmed: 26235627
Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
pubmed: 29126249
Protein Cell. 2018 Feb;9(2):216-237
pubmed: 28748451
Cancers (Basel). 2014 Jul 03;6(3):1408-40
pubmed: 24995504
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293
Mol Cancer Ther. 2018 Sep;17(9):2004-2012
pubmed: 29907593
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Front Biosci (Landmark Ed). 2009 Jan 01;14(8):2944-58
pubmed: 19273247
Cell Rep. 2017 May 30;19(9):1888-1901
pubmed: 28564606
Science. 2009 Feb 6;323(5915):793-7
pubmed: 19131594
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Mol Cancer. 2006 May 15;5:17
pubmed: 16700911
Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):811-6
pubmed: 14711987
Int J Cancer. 2018 Jul 15;143(2):396-407
pubmed: 29441565
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Front Oncol. 2015 Jun 08;5:121
pubmed: 26106584
Cell Cycle. 2008 Apr 15;7(8):1054-66
pubmed: 18414044
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Mol Cell Biol. 2001 Mar;21(5):1621-32
pubmed: 11238899
Cancer Res. 2012 Oct 1;72(19):5130-40
pubmed: 22850421
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
J Biol Chem. 1997 Nov 14;272(46):28875-81
pubmed: 9360955
Eur Urol. 2018 Apr;73(4):524-532
pubmed: 28330676
Mol Cell Proteomics. 2012 Mar;11(3):M111.014068
pubmed: 22301388
Proteomics. 2015 Apr;15(8):1453-6
pubmed: 25644178
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
J Stat Softw. 2012 Mar;46(11):
pubmed: 23050260
Nature. 2009 Nov 5;462(7269):108-12
pubmed: 19847166
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
Cancer Res. 2012 Apr 1;72(7):1602-7
pubmed: 22282659
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Oncogene. 2013 Jan 3;32(1):70-7
pubmed: 22349817
Bioinformatics. 2007 Apr 15;23(8):980-7
pubmed: 17303618
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
PLoS One. 2013 Sep 16;8(9):e74250
pubmed: 24066126
J Clin Pathol. 2006 Jan;59(1):10-6
pubmed: 16394275
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Cancers (Basel). 2014 Apr 16;6(2):897-925
pubmed: 24743777
J Natl Cancer Inst. 2017 Nov 1;109(11):
pubmed: 29059435
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cancer Metab. 2014 Nov 03;2(1):20
pubmed: 25379179
Nat Med. 2016 Mar;22(3):298-305
pubmed: 26855148
Bioinformatics. 2017 Feb 1;33(3):414-424
pubmed: 27694195
Mol Syst Biol. 2020 Apr;16(4):e9247
pubmed: 32323921
PLoS One. 2014 May 27;9(5):e98032
pubmed: 24865588
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Nat Rev Urol. 2018 Oct;15(10):627-642
pubmed: 30065357
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
J Urol. 1974 Jan;111(1):58-64
pubmed: 4813554
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Nat Methods. 2013 Nov;10(11):1046-7
pubmed: 24037243
Mech Dev. 2001 Mar;101(1-2):61-9
pubmed: 11231059
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Am J Surg Pathol. 2005 Sep;29(9):1228-42
pubmed: 16096414
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Nat Commun. 2018 Mar 21;9(1):1176
pubmed: 29563510
Mol Cell Biol. 2007 Jun;27(12):4444-53
pubmed: 17438134
Nat Commun. 2018 Nov 21;9(1):4900
pubmed: 30464211
Nutr Metab (Lond). 2014 Feb 12;11(1):10
pubmed: 24520982
Bioinformatics. 2007 May 15;23(10):1289-91
pubmed: 17379693
J Biol Chem. 2010 Jul 30;285(31):23532-6
pubmed: 20558729
Cell Death Differ. 2019 May;26(5):932-942
pubmed: 30042492

Auteurs

Monika Oberhuber (M)

Department of Pathology, Medical University of Vienna, Vienna, Austria.
CBmed-Center for Biomarker Research in Medicine GmbH, Graz, Austria.

Matteo Pecoraro (M)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.

Mate Rusz (M)

Department of Analytical Chemistry, University of Vienna, Vienna, Austria.
Institute of Inorganic Chemistry, University of Vienna, Vienna, Austria.

Georg Oberhuber (G)

Patho im Zentrum, St.Pölten, Austria.

Maritta Wieselberg (M)

Department of Pathology, Medical University of Vienna, Vienna, Austria.
CBmed-Center for Biomarker Research in Medicine GmbH, Graz, Austria.

Peter Haslinger (P)

Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria.

Elisabeth Gurnhofer (E)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Michaela Schlederer (M)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Tanja Limberger (T)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Sabine Lagger (S)

Unit of Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, Vienna, Austria.

Jan Pencik (J)

Department of Pathology, Medical University of Vienna, Vienna, Austria.
CBmed-Center for Biomarker Research in Medicine GmbH, Graz, Austria.

Petra Kodajova (P)

Unit of Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, Vienna, Austria.

Sandra Högler (S)

Unit of Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, Vienna, Austria.

Georg Stockmaier (G)

Department of Biosciences, University of Salzburg, Salzburg, Austria.

Sandra Grund-Gröschke (S)

Department of Biosciences, University of Salzburg, Salzburg, Austria.

Fritz Aberger (F)

Department of Biosciences, University of Salzburg, Salzburg, Austria.

Marco Bolis (M)

Institute of Oncology Research (IOR), Bellinzona, Switzerland.
Università delle Svizzera italiana, Lugano, Switzerland.

Jean-Philippe Theurillat (JP)

Institute of Oncology Research (IOR), Bellinzona, Switzerland.
Università delle Svizzera italiana, Lugano, Switzerland.

Robert Wiebringhaus (R)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Theresa Weiss (T)

Department of Pathology, Medical University of Vienna, Vienna, Austria.
CBmed-Center for Biomarker Research in Medicine GmbH, Graz, Austria.

Andrea Haitel (A)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Marc Brehme (M)

CBmed-Center for Biomarker Research in Medicine GmbH, Graz, Austria.

Wolfgang Wadsak (W)

CBmed-Center for Biomarker Research in Medicine GmbH, Graz, Austria.
Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Johannes Griss (J)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Thomas Mohr (T)

Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Science Consult DI, Thomas Mohr KG, Guntramsdorf, Austria.

Alexandra Hofer (A)

Research Area Biochemical Engineering, Institute of Chemical, Environmental and Biological Engineering, Vienna University of Technology, Vienna, Austria.

Anton Jäger (A)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Jürgen Pollheimer (J)

Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria.

Gerda Egger (G)

Department of Pathology, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.

Gunda Koellensperger (G)

Department of Analytical Chemistry, University of Vienna, Vienna, Austria.

Matthias Mann (M)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.

Brigitte Hantusch (B)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Lukas Kenner (L)

Department of Pathology, Medical University of Vienna, Vienna, Austria.
CBmed-Center for Biomarker Research in Medicine GmbH, Graz, Austria.
Unit of Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, Vienna, Austria.
Christian Doppler Laboratory for Applied Metabolomics (CDL AM), Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Platform for Comparative Laboratory Animal Pathology, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH